Redhill Biopharma Total Assets 2013-2025 | RDHL

Redhill Biopharma total assets from 2013 to 2025. Total assets can be defined as the sum of all assets on a company's balance sheet.
Redhill Biopharma Annual Total Assets
(Millions of US $)
2024 $18
2023 $23
2022 $159
2021 $181
2020 $180
2019 $74
2018 $62
2017 $57
2016 $74
2015 $67
2014 $29
2013 $14
2012 $20
Redhill Biopharma Quarterly Total Assets
(Millions of US $)
2022-12-31 $159
2022-09-30 $157
2022-06-30 $168
2022-03-31 $167
2021-12-31 $181
2021-09-30 $186
2021-06-30 $204
2021-03-31 $220
2020-12-31 $180
2020-09-30 $169
2020-06-30 $166
2020-03-31 $143
2019-12-31 $74
2019-09-30 $40
2019-06-30 $50
2019-03-31 $58
2018-12-31 $62
2018-09-30 $53
2018-06-30 $38
2018-03-31 $46
2017-12-31 $57
2017-09-30 $50
2017-06-30 $62
2017-03-31 $70
2016-12-31 $74
2016-09-30 $49
2016-06-30 $56
2016-03-31 $62
2015-12-31 $67
2015-09-30 $72
2015-06-30 $34
2015-03-31 $41
2014-12-31 $29
2014-09-30 $34
2014-06-30 $39
2014-03-31 $41
2013-12-31 $14
2013-09-30 $16
2013-06-30 $17
2013-03-31 $19
2012-12-31 $20
2012-09-30 $0
2012-06-30 $0
2012-03-31 $0
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.007B $0.008B
RedHill Biopharma Ltd. is a specialty biopharmaceutical company, focused on gastrointestinal and infectious diseases. It operates through the Commercial Operations segment and the Research & Development segment. The Commercial Operations segment is based in Raleigh, NC, and covers all areas relating to the commercial sales and operating expenses directly related to that activity and is being performed by the Company's subsidiary in the United States. The Research & Development segment includes all activities related to the research and development of therapeutic candidates. The company was founded in 2009 and is headquartered in Tel Aviv, Israel.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $84.909B 32.25
Zoetis (ZTS) United States $54.311B 19.44
Takeda Pharmaceutical (TAK) Japan $51.389B 10.49
Daiichi Sankyo, - (DSNKY) Japan $38.891B 19.37
BeOne Medicines - (ONC) Switzerland $36.658B 194.35
Sandoz Group AG (SDZNY) Switzerland $33.832B 0.00
United Therapeutics (UTHR) United States $20.154B 17.74
Merck (MKKGY) Germany $19.005B 11.72
Shionogi (SGIOY) Japan $15.636B 14.36
Neurocrine Biosciences (NBIX) United States $13.414B 32.19
IPSEN (IPSEY) France $12.891B 0.00
Ionis Pharmaceuticals (IONS) United States $12.558B 0.00
Summit Therapeutics (SMMT) United States $12.385B 0.00
Madrigal Pharmaceuticals (MDGL) United States $11.468B 0.00
Orion OYJ (ORINY) Finland $10.204B 29.15
Eisai (ESAIY) $8.120B 0.00
Ono Pharmaceutical (OPHLF) Japan $6.967B 21.19
Grifols, S.A (GRFS) Spain $5.940B 0.00
Stevanato Group S.p.A (STVN) Italy $5.784B 32.37
Crinetics Pharmaceuticals (CRNX) United States $5.285B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.613B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $4.190B 19.90
Indivior (INDV) United States $4.119B 16.81
Corcept Therapeutics (CORT) United States $3.712B 40.10
NewAmsterdam Pharma (NAMS) Netherlands $3.675B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $3.081B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.874B 9.17
Hypermarcas (HYPMY) Brazil $2.755B 18.91
Ocular Therapeutix (OCUL) United States $2.439B 0.00
Dyne Therapeutics (DYN) United States $2.368B 0.00
Soleno Therapeutics (SLNO) United States $2.349B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $2.100B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.950B 23.11
Ardelyx (ARDX) United States $1.885B 0.00
Amylyx Pharmaceuticals (AMLX) United States $1.818B 0.00
Guardian Pharmacy Services (GRDN) United States $1.793B 34.54
Harrow (HROW) United States $1.767B 108.46
Oruka Therapeutics (ORKA) United States $1.609B 0.00
Enliven Therapeutics (ELVN) United States $1.605B 0.00
Collegium Pharmaceutical (COLL) United States $1.508B 7.46
BioCryst Pharmaceuticals (BCRX) United States $1.406B 83.38
Relay Therapeutics (RLAY) United States $1.284B 0.00
Xeris Biopharma Holdings (XERS) United States $1.263B 0.00
Savara (SVRA) United States $1.215B 0.00
Evotec AG (EVO) Germany $1.204B 0.00
Theravance Biopharma (TBPH) United States $1.035B 43.45
ARS Pharmaceuticals (SPRY) United States $1.033B 0.00
Cronos Group (CRON) Canada $0.973B 0.00
Aktis Oncology (AKTS) United States $0.951B 0.00
Xencor (XNCR) United States $0.903B 0.00
KalVista Pharmaceuticals (KALV) United States $0.774B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.745B 17.61
Nektar Therapeutics (NKTR) United States $0.737B 0.00
Esperion Therapeutics (ESPR) United States $0.691B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.660B 5.89
ProKidney (PROK) United States $0.644B 0.00
Bioventus (BVS) United States $0.638B 13.07
Lexeo Therapeutics (LXEO) United States $0.530B 0.00
Zevra Therapeutics (ZVRA) United States $0.508B 0.00
Lyell Immunopharma (LYEL) United States $0.508B 0.00
Elite Pharmaceuticals (ELTP) United States $0.505B 0.00
Aclaris Therapeutics (ACRS) United States $0.480B 0.00
Organogenesis (ORGO) United States $0.471B 0.00
Siga Technologies (SIGA) United States $0.468B 6.41
Altimmune (ALT) United States $0.441B 0.00
4D Molecular Therapeutics (FDMT) United States $0.435B 0.00
Aquestive Therapeutics (AQST) United States $0.425B 0.00
Nature's Sunshine Products (NATR) United States $0.418B 24.91
USANA Health Sciences (USNA) United States $0.402B 11.21
Cybin (HELP) Canada $0.383B 0.00
Akebia Therapeutics (AKBA) United States $0.356B 0.00
Achieve Life Sciences (ACHV) Canada $0.292B 0.00
Protara Therapeutics (TARA) United States $0.289B 0.00
Relmada Therapeutics (RLMD) United States $0.289B 0.00
Profound Medical (PROF) Canada $0.286B 0.00
Aldeyra Therapeutics (ALDX) United States $0.286B 0.00
Avalo Therapeutics (AVTX) United States $0.274B 0.00
OmniAb (OABI) United States $0.274B 0.00
Larimar Therapeutics (LRMR) United States $0.265B 0.00
Fractyl Health (GUTS) United States $0.262B 0.00
Heron Therapeutics (HRTX) United States $0.260B 0.00
Silence Therapeutics (SLN) United Kingdom $0.246B 0.00
Journey Medical (DERM) United States $0.237B 0.00
Enlivex Therapeutics (ENLV) Israel $0.233B 0.00
MediWound (MDWD) Israel $0.218B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.207B 0.00
Galectin Therapeutics (GALT) United States $0.193B 0.00
Minerva Neurosciences (NERV) United States $0.189B 0.00
AleAnna (ANNA) United States $0.183B 0.00
Innate Pharma SA (IPHYF) France $0.181B 0.00
Century Therapeutics (IPSC) United States $0.168B 0.00
VAXART, INC (VXRT) United States $0.166B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.161B 0.00
Surrozen (SRZN) United States $0.154B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.151B 0.00
Context Therapeutics (CNTX) United States $0.141B 0.00
Unicycive Therapeutics (UNCY) United States $0.141B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.127B 0.00
Inhibikase Therapeutics (IKT) United States $0.124B 0.00
Incannex Healthcare (IXHL) Australia $0.124B 0.00
Prelude Therapeutics (PRLD) United States $0.116B 0.00
Avita Medical (RCEL) United States $0.115B 0.00
Karyopharm Therapeutics (KPTI) United States $0.109B 0.00
Pyxis Oncology (PYXS) United States $0.103B 0.00
Cardiol Therapeutics (CRDL) Canada $0.101B 0.00
Vivani Medical (VANI) United States $0.099B 0.00
Champions Oncology (CSBR) United States $0.097B 41.18
Cassava Sciences (SAVA) United States $0.096B 0.00
Korro Bio (KRRO) United States $0.081B 0.00
Gain Therapeutics (GANX) United States $0.077B 0.00
Assertio Holdings (ASRT) United States $0.075B 0.00
PolyPid (PYPD) Israel $0.071B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.071B 59.00
Dominari Holdings (DOMH) United States $0.067B 0.00
NRx Pharmaceuticals (NRXP) United States $0.065B 0.00
Arch Biopartners (ACHFF) Canada $0.064B 0.00
Rafael Holdings (RFL) United States $0.063B 0.00
Acrivon Therapeutics (ACRV) United States $0.062B 0.00
Metagenomi (MGX) United States $0.060B 0.00
PMV Pharmaceuticals (PMVP) United States $0.057B 0.00
Nutriband (NTRB) United States $0.056B 0.00
Lipocine (LPCN) United States $0.055B 0.00
ElectroCore (ECOR) United States $0.055B 0.00
Lite Strategy (LITS) United States $0.048B 0.00
Talphera (TLPH) United States $0.046B 0.00
Telomir Pharmaceuticals (TELO) United States $0.046B 0.00
Plus Therapeutics (PSTV) United States $0.040B 0.00
FibroGen (FGEN) United States $0.039B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.039B 0.00
Mural Oncology (MURA) Ireland $0.035B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.035B 0.00
Wellgistics Health (WGRX) United States $0.035B 0.00
Jupiter Neurosciences (JUNS) United States $0.031B 0.00
Natural Alternatives (NAII) United States $0.030B 0.00
TherapeuticsMD (TXMD) United States $0.029B 0.00
SCYNEXIS (SCYX) United States $0.027B 0.00
Klotho Neurosciences (KLTO) United States $0.023B 0.00
Traws Pharma (TRAW) United States $0.021B 0.03
Scienture Holdings (SCNX) United States $0.020B 0.00
Liminatus Pharma (LIMN) United States $0.020B 0.00
VYNE Therapeutics (VYNE) United States $0.019B 0.00
Inotiv (NOTV) United States $0.019B 0.00
Vivos Therapeutics (VVOS) United States $0.019B 0.00
Cosmos Health (COSM) United States $0.019B 0.00
Iterum Therapeutics (ITRM) Ireland $0.018B 0.00
Citius Pharmaceuticals (CTXR) United States $0.017B 0.00
Vyome Holdings (HIND) United States $0.016B 0.00
Mannatech (MTEX) United States $0.014B 0.00
Tempest Therapeutics (TPST) United States $0.013B 0.00
BioLineRx (BLRX) Israel $0.012B 0.00
CASI Pharmaceuticals (CASI) China $0.012B 0.00
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
China SXT Pharmaceuticals (SXTC) China $0.011B 0.00
Curanex Pharmaceuticals Inc (CURX) United States $0.011B 0.00
Addex Therapeutics (ADXN) Switzerland $0.010B 0.00
Mangoceuticals (MGRX) United States $0.010B 0.00
Ernexa Therapeutics (ERNA) United States $0.010B 0.00
BioVie (BIVI) United States $0.009B 0.00
Ainos (AIMD) United States $0.009B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.009B 0.00
Nuvilex (PMCB) United States $0.009B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Heatwurx (PCSA) United States $0.007B 0.00
Alaunos Therapeutics (TCRT) United States $0.007B 0.00
Aptorum Group (APM) United Kingdom $0.006B 0.00
Indaptus Therapeutics (INDP) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.005B 0.00
Lyra Therapeutics (LYRA) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
CDT Equity (CDT) United States $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.001B 0.00
Aditxt (ADTX) United States $0.001B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Emisphere Technologies (EMIS) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00